| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/07/2004 | CN1144816C Novel antproliferative protein from bacillus thuringiensis var. Thuringiensis |
| 04/07/2004 | CN1144815C Modified i CE.(oli) enterotoxin II signal peptide and microorganism expressing fusion protein of said peptide and heterologous protein |
| 04/06/2004 | US6716965 Adipocyte complement related protein zacrp13 |
| 04/06/2004 | US6716816 Dyslipidemia, hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock. |
| 04/06/2004 | US6716621 Isolated DNA or gene responsible for Parkinson's disease |
| 04/06/2004 | US6716612 Modifying the branching degree of amylopectin synthesized in plants, |
| 04/06/2004 | US6716603 Nucleic acids encoding a chloride channel protein |
| 04/06/2004 | US6716602 Metabolic rate shifts in fermentations expressing recombinant proteins |
| 04/06/2004 | US6716601 Controlling the expression of homologous and heterologous nucleic acid molecules in yeast cells. |
| 04/06/2004 | US6716598 Isolating adjusted polypeptide; obtain sample, incubate with binding agent, filter mixture, remove leaching agent, isolate polypeptide |
| 04/06/2004 | US6716587 Antiinflammatory |
| 04/06/2004 | US6716575 Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
| 04/06/2004 | CA2269077C Keratinocyte growth factor-2 products |
| 04/06/2004 | CA2196296C Production of tissue factor pathway inhibitor |
| 04/06/2004 | CA2147372C Multidrug resistance gene |
| 04/06/2004 | CA2042016C Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 04/06/2004 | CA2010321C Lymphocyte-associated cell surface protein |
| 04/01/2004 | WO2004027429A1 Process for differential diagnosis of alzheimer's dementia in patients exhibiting mild cognitive impairment |
| 04/01/2004 | WO2004027077A1 Cell-free protein synthesis solution, process for producing the same and utilization of the same |
| 04/01/2004 | WO2004027072A2 Method for making recombinant proteins |
| 04/01/2004 | WO2004027067A2 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 04/01/2004 | WO2004027059A1 Process for producing ligand binding protein with the use of cell-free protein synthesis system and utilization thereof |
| 04/01/2004 | WO2004027049A2 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 04/01/2004 | WO2004027043A2 Method for production of a multimeric protein by cell fusion |
| 04/01/2004 | WO2004026427A2 Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds |
| 04/01/2004 | WO2004026120A2 Methods for diagnosing and treating tumors and suppressing cd promoters |
| 04/01/2004 | WO2004018681A3 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 04/01/2004 | WO2004009762A9 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 04/01/2004 | WO2004007723A3 Genes |
| 04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2004 | WO2004005473A3 Hcv fusion proteins with modified ns3 domains |
| 04/01/2004 | WO2003100082A8 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 04/01/2004 | WO2003087840A3 Protein involved in cancer |
| 04/01/2004 | WO2003087838A3 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (mbl) |
| 04/01/2004 | WO2003062270B1 Fluorescent protein from aequorea coerulscens and uses therof |
| 04/01/2004 | WO2003060090A3 Novel cytokine zcytor17 ligand |
| 04/01/2004 | WO2003050283A3 A structure for presenting desired peptide sequences |
| 04/01/2004 | WO2003031940A3 Structural and cytoskeleton-associated proteins |
| 04/01/2004 | WO2003014161A9 Antigen binding domains from fish |
| 04/01/2004 | WO2003012044A9 Hagfish cathelin-associated antimicrobial peptides and genes |
| 04/01/2004 | WO2002092758A3 Gastrokines and derived peptides including inhibitors |
| 04/01/2004 | WO2002069900A3 Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors |
| 04/01/2004 | WO2002058637A9 Compositions and methods for diagnosis of neuropsychiatric disorders |
| 04/01/2004 | US20040063921 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/01/2004 | US20040063917 Modified erythropoietin (epo) with reduced immunogenicity |
| 04/01/2004 | US20040063913 Antibodies to human il-1beta |
| 04/01/2004 | US20040063908 Comprises genetically engineered hemophilus adherence and penetration (HAP) proteins for treatment and prevention of influenza; immunotherapy |
| 04/01/2004 | US20040063634 Modified kertinocyte growth factor (kgf) with reduced immunogenicity |
| 04/01/2004 | US20040063633 Interleukin-18 inducing agent |
| 04/01/2004 | US20040063632 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 04/01/2004 | US20040063621 Heterocarpine, a human ghrh-binding protein |
| 04/01/2004 | US20040063188 Kit for treating gastrointestinal tract |
| 04/01/2004 | US20040063186 Vectors and methods for recombinant protein expression |
| 04/01/2004 | US20040063177 Generating subtilisin mutant with decreased immunogenicity for use in laundry detergents, cosmetics and textile treatment |
| 04/01/2004 | US20040063164 Kit and method for detecting the esm-1 protein |
| 04/01/2004 | US20040063140 Methods for diagnosis of cancer using erbB-3 |
| 04/01/2004 | US20040063135 Comprises oligonucleotides for determining concentration of glucuonidase in cell culture; detection and monitoring of malignancies and metastasis; targeted drug delivery |
| 04/01/2004 | US20040063131 Comprises neuroendocrine-specific proteins-like polypeptides (NSPLP) for diagnosis, prevention and treatment of neurodegenerative and cell proliferative diseases |
| 04/01/2004 | US20040063127 Comprises nuclelotide sequences coding cytokine for diagnosis, prevention and treatment of infection, hepatitis, nephritis, cancer and autoimmune diseases |
| 04/01/2004 | US20040063125 Transgenic cells coding membrane protein which controls intracellular hydrogen ion concentration for identifying modulators for treatment of diabetes |
| 04/01/2004 | US20040063092 Immunoassays for anti-HCV antibodies |
| 04/01/2004 | US20040062749 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 04/01/2004 | CA2499644A1 Process for producing ligand binding protein with the use of cell-free protein synthesis system and utilization thereof |
| 04/01/2004 | CA2499467A1 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 04/01/2004 | CA2499269A1 Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds |
| 04/01/2004 | CA2499066A1 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 04/01/2004 | CA2498881A1 Process for differential diagnosis of alzheimer's dementia in patients exhibiting mild cognitive impairment |
| 03/31/2004 | EP1403376A2 Expression of heterologous genes according to a targeted expression profile |
| 03/31/2004 | EP1403375A2 Recombinant live avian vaccin, using avian herpes virus as vector |
| 03/31/2004 | EP1403370A1 Polynucleotide probe and primer for detecting beer-clouding lactic acid bacteria and method of detecting beer-clouding lactic acid bacteria |
| 03/31/2004 | EP1403368A1 Testicular carnitine transporter and its gene |
| 03/31/2004 | EP1403367A1 Method of testing drug for treating or preventing diseases such as hyperlipemia |
| 03/31/2004 | EP1403285A1 Fibroblast growth factor receptors |
| 03/31/2004 | EP1403274A1 Process for the purification of recombinant proteins from complex media and purified proteins obtained thereby |
| 03/31/2004 | EP1402897A2 Novel indications of Mannan-binding lectin (MBL) in the treatment of immunocompromised individuals |
| 03/31/2004 | EP1402260A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 03/31/2004 | EP1402256A2 P-cadherin as a target for anti-cancer therapy |
| 03/31/2004 | EP1402064A2 Protein arrays and methods and systems for producing the same |
| 03/31/2004 | EP1402058A2 Dgks as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1402054A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 03/31/2004 | EP1402053A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 03/31/2004 | EP1402050A2 Methods for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gp41 fragments |
| 03/31/2004 | EP1402036A2 Expression vectors encoding bacteriophage signal peptides |
| 03/31/2004 | EP1402035A2 G-protein coupled receptors and dna sequences thereof |
| 03/31/2004 | EP1402032A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis |
| 03/31/2004 | EP1402031A2 Atopy |
| 03/31/2004 | EP1402024A2 Templated molecules and methods for using such molecules |
| 03/31/2004 | EP1402015A2 A soluble complex comprising a retroviral surface glycoprotein |
| 03/31/2004 | EP1402006A1 Compositions and methods for high-level, large-scale production of recombinant proteins |
| 03/31/2004 | EP1402000A2 Structural and cytoskeleton-associated proteins |
| 03/31/2004 | EP1401999A2 B7 related protein-2 molecules and uses thereof |
| 03/31/2004 | EP1401869A1 Molecules and methods for inhibiting shedding of kim-1 |
| 03/31/2004 | EP1401857A2 Purification of human serum albumin |
| 03/31/2004 | EP1401855A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 03/31/2004 | EP1401851A1 Two-stage protective groups for the synthesis of biopolymers |
| 03/31/2004 | EP1401490A1 Tsg101 as inhibitor of hiv production |
| 03/31/2004 | EP1401475A2 Prmts as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 03/31/2004 | EP1401470A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 03/31/2004 | EP1401281A2 Toll/interleukin-1 receptor adaptor protein (tirap) |